Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
103 Cards in this Set
- Front
- Back
Acute Pain
|
Discomfort identified by sudden onset and relatively short duration, mild to severe intensity, and a steady decrease in intensity over several days or weeks.
|
|
Discomfort identified by sudden onset and relatively short duration, mild to severe intensity, and a steady decrease in intensity over several days or weeks.
|
Acute Pain
|
|
Chronic nonmalignant pain or
Chronic benign pain |
Discomfort that occurs almost daily, has been present for at least 6 months, and ranges in intensity from mild to severe
|
|
Discomfort that occurs almost daily, has been present for at least 6 months, and ranges in intensity from mild to severe
|
Chronic nonmalignant pain or
Chronic benign pain |
|
Descending spinal cord pathway that transmits sensory impulses from the brain.
|
Efferent Pain Pathway
|
|
Efferent Pain Pathway
|
Descending spinal cord pathway that transmits sensory impulses from the brain.
|
|
Neuropathic pain that occurs after amputation with pain sensations referred to an area in the missing portion of the limb.
|
Phantom Limb Pain
|
|
Phantom Limb Pain
|
Neuropathic pain that occurs after amputation with pain sensations referred to an area in the missing portion of the limb.
|
|
Unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such.
|
Pain
|
|
Pain
|
Unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such.
|
|
Compound that blocks opioid effects on one receptor type while producing opioid effects on a second receptor type.
|
Mixed Agonist - Antagonist
|
|
Mixed Agonist - Antagonist
|
Compound that blocks opioid effects on one receptor type while producing opioid effects on a second receptor type.
|
|
Drug used to enhance the analgesic efficacy of opioids, treat concurrent symptoms that exacerbate pain and provide independent analgesia for specific types of pain.
|
Adjuvant medication
|
|
Adjuvant medication
|
Drug used to enhance the analgesic efficacy of opioids, treat concurrent symptoms that exacerbate pain and provide independent analgesia for specific types of pain.
|
|
Use of cold applications to reduce swelling
|
cryotherapy
|
|
cryotherapy
|
Use of cold applications to reduce swelling
|
|
Analgesics administered via a catheter that terminates in the epidural space.
|
Epidural Analgesia
|
|
Epidural Analgesia
|
Analgesics administered via a catheter that terminates in the epidural space.
|
|
Technique of focusing attention on stimuli other than pain.
|
Distraction
|
|
Distraction
|
Technique of focusing attention on stimuli other than pain.
|
|
Hypnosis
|
State of heightened awareness and focused concentration. An altered state of consciousness when a person in more receptive to suggestion.
|
|
State of heightened awareness and focused concentration. An altered state of consciousness when a person in more receptive to suggestion.
|
Hypnosis
|
|
Discomfort from the internal organs that is felt in another area of the body
|
Referred pain
|
|
Referred pain
|
Discomfort from the internal organs that is felt in another area of the body
|
|
Stress management strategy in which muscles are alternately tensed and relaxed.
|
Progressive muscle relaxation
|
|
Progressive muscle relaxation
|
Stress management strategy in which muscles are alternately tensed and relaxed.
|
|
Underlying pathology that causes pain.
|
Noxious Stimulus
|
|
Noxious Stimulus
|
Underlying pathology that causes pain.
|
|
Central Nervous system pathway that selectively inhibits pain transmission by sending signals back down to the dorsal horn of the spinal cord.
|
Modulation
|
|
Modulation
|
Central Nervous system pathway that selectively inhibits pain transmission by sending signals back down to the dorsal horn of the spinal cord.
|
|
Paroximal pain that extends along the course of one or more nerves
|
Neuralgia
|
|
Neuralgia
|
Paroximal pain that extends along the course of one or more nerves
|
|
Noxious stimulus that triggers electrical activity in the endings of afferent nerve fibers (nociceptors)
|
Transduction
|
|
Transduction
|
Noxious stimulus that triggers electrical activity in the endings of afferent nerve fibers (nociceptors)
|
|
Process of applying a low voltage electrical current to the skin through cutaneous electrodes
|
Transcutaneous Electrical nerve stimulation (TENS)
|
|
Transcutaneous Electrical nerve stimulation (TENS)
|
Process of applying a low voltage electrical current to the skin through cutaneous electrodes
|
|
Phenomenon of requiring larger and larger doses of an analgesic to achieve the same level of pain relief.
|
Tolerance
|
|
Tolerance
|
Phenomenon of requiring larger and larger doses of an analgesic to achieve the same level of pain relief.
|
|
Discomfort resulting when the blood supply of an area is restricted or cut off completely.
|
Ischemic Pain
|
|
Ischemic Pain
|
Discomfort resulting when the blood supply of an area is restricted or cut off completely.
|
|
Level of intensity at which pain becomes appreciable or perceptible
|
Pain Threshold
|
|
Pain Threshold
|
Level of intensity at which pain becomes appreciable or perceptible
|
|
Device that allows the client to control the delivery of intravenous or subcutaneous pain medication in a safe, effective manner through a programmable pump.
|
Patient controlled analgesia
|
|
Patient controlled analgesia
|
Device that allows the client to control the delivery of intravenous or subcutaneous pain medication in a safe, effective manner through a programmable pump.
|
|
Discomfort marked by repetitive painful episodes that may recur over a prolonged period or throughout a clients lifetime.
|
Recurrent Acute Pain
|
|
Recurrent Acute Pain
|
Discomfort marked by repetitive painful episodes that may recur over a prolonged period or throughout a clients lifetime.
|
|
Technique of monitoring negative thoughts and replacing them with positive ones.
|
Reframing
|
|
Reframing
|
Technique of monitoring negative thoughts and replacing them with positive ones.
|
|
Discomfort caused by stimulation of the cutaneous nerve endings in the skin.
|
Cutaneous Pain
|
|
Cutaneous Pain
|
Discomfort caused by stimulation of the cutaneous nerve endings in the skin.
|
|
Group of opiate-like substances produced naturally by the brain; these substances raise the pain threshold, produce sedation and euphoria, and promote a sense of well-being
|
Endorphins
|
|
Endorphins
|
Group of opiate-like substances produced naturally by the brain; these substances raise the pain threshold, produce sedation and euphoria, and promote a sense of well-being
|
|
Pain relief without producing anesthesia
|
Analgesia
|
|
Analgesia
|
Pain relief without producing anesthesia
|
|
Ascending spinal cord
|
Afferent pain pathway
|
|
Afferent pain pathway
|
Ascending spinal cord
|
|
Administration of analgesics into the subarachnoid space
|
Intrathecal analgesia
|
|
Intrathecal analgesia
|
Administration of analgesics into the subarachnoid space
|
|
Receptive neuron for painful sensations
|
Nociceptor
|
|
Nociceptor
|
Receptive neuron for painful sensations
|
|
Nonlocalized discomfort originating in tendons, ligaments and nerves
|
Somatic Pain
|
|
Somatic Pain
|
Nonlocalized discomfort originating in tendons, ligaments and nerves
|
|
Level of intensity or duration of pain that a person is willing to endure
|
Pain Tolerance
|
|
Pain Tolerance
|
Level of intensity or duration of pain that a person is willing to endure
|
|
Discomfort generally identified as long term (lasting longer than 6 months) that is persistent, nearly constant or recurrent and that produces significant negative changes in a persons life.
|
Chronic Pain
|
|
Chronic Pain
|
Discomfort generally identified as long term (lasting longer than 6 months) that is persistent, nearly constant or recurrent and that produces significant negative changes in a persons life.
|
|
Insertion of small needles into the skin at selected (hoku) sites
|
Accupuncture
|
|
Accupuncture
|
Insertion of small needles into the skin at selected (hoku) sites
|
|
Substance that relieves pain
|
analgesic
|
|
analgesic
|
Substance that relieves pain
|
|
Condition of acute abdominal pain
|
Colic
|
|
Colic
|
Condition of acute abdominal pain
|
|
Discomfort that occurs almost daily over a long period, has the potential for lasting months or years, and has a high probability of ending; also known as progressive pain.
|
Chronic Acute Pain
|
|
Chronic Acute Pain
|
Discomfort that occurs almost daily over a long period, has the potential for lasting months or years, and has a high probability of ending; also known as progressive pain.
|
|
Theory that proposes that the cognitive, sensory, emotional, and physiological components of the body can act together to block an individuals perception of pain.
|
Gate control pain theory
|
|
Gate control pain theory
|
Theory that proposes that the cognitive, sensory, emotional, and physiological components of the body can act together to block an individuals perception of pain.
|
|
Group of muscle disorders characterized by pain, muscle spasm, tenderness, stiffness and limited motion
|
myofascial pain syndromes
|
|
myofascial pain syndromes
|
Group of muscle disorders characterized by pain, muscle spasm, tenderness, stiffness and limited motion
|
|
Process by where the pain impulse travels from the receiving nociceptors to the spinal cord
|
Transmission
|
|
Transmission
|
Process by where the pain impulse travels from the receiving nociceptors to the spinal cord
|
|
Method used to decrease anxiety and muscle tension
|
Relaxation Technique
|
|
Relaxation Technique
|
Method used to decrease anxiety and muscle tension
|
|
Discomfort felt in the internal organs
|
visceral pain
|
|
visceral pain
|
Discomfort felt in the internal organs
|
|
Ability to experience, recognize, organize, and interpret sensory stimuli
|
Perception
|
|
Perception
|
Ability to experience, recognize, organize, and interpret sensory stimuli
|
|
Medication dosage beyond which no further analgesia occurs
|
Ceiling effect
|
|
Ceiling effect
|
Medication dosage beyond which no further analgesia occurs
|
|
APS
|
American Pain Society
|
|
AHCPR
|
Agency for Health Care Policy and Research
|
|
ATC
|
Around the Clock
|
|
EMLA
|
Eutectic (Cream) mixture of local anesthetics
|
|
IASP
|
International Association for the Study of Pain
|
|
MRI
|
Magnetic Resonance Imaging
|
|
NPO
|
Nothing by mouth
|
|
NSAID
|
Nonsteroidal anti-inflammatory drug
|
|
PCA
|
Patient controlled analgesia
|
|
PRN
|
As required
|
|
TAC
|
Tetracaine, Adrenaline, Cocaine
|
|
TENS
|
Transcutaneous electrical nerve stimulation
|
|
TMJ
|
Temporomandibular joint
|
|
VAS
|
Visual Analog Scale
|
|
WHO
|
World Health Organization
|